SEC Form 4 · accession 0001605411-18-000003
Nuo Therapeutics, Inc. · AURX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Emerson Jorden
Officer — CEO, CFO · Director
Period of report
Aug 9, 2018
Accepted (ET)
Aug 13, 2018 · 4:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001091596
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock | $0.40 | Aug 9, 2018 | A | 192,710 | A | Aug 9, 2018 | Aug 9, 2025 | COMMON STOCK | 192,710 | 192,710 | D |